Ex vivo kidney resection in pharmacological cold ischemia followed by orthotopic autotransplantation
Abstract
Introduction. One of the priorities in oncology includes the development of alternative organoprotection treatments for renal cell carcinoma (RCC) of intraparenchymal and central tumor location.
Study objective was to develop the method of extracorporeal kidney resection without ureter transection in conditions of pharmacological cold ischemia, followed by an orthotopic autotransplantation for RCC.
Materials and methods. The study included 37 patients who had a morphologically confirmed RCC of stage pT1a-T3bN0M0-1G1-3 with intraparenchymal and central tumour location.
Results. The mean duration of surgery was 413.97 ± 89.14 minutes. The mean cold and warm ischemia time of kidney was 151.41 ± 41.29 minutes, and 8.39 ± 4.75 minutes, respectively. Intraoperative complications made 8.1% (3), postoperative complication rate was 48.6% (18).
Conclusion. Extracorporeal kidney resection without ureter transection in conditions of pharmacological cold ischemia, followed by an orthotopic autotransplantation in RCC allows the resection of large tumors in any location in conditions of prolonged cold ischemia.
About the Authors
A. A. Gritskevich
A.V. Vishnevsky Institute of Surgery, Moscow
Russian Federation
Cand.Med.Sci., Senior Research Associate of Urology Department
Russian Federation
Cand.Med.Sci., Senior Research Associate of Urology Department
S. S. P'yanikin
A.V. Vishnevsky Institute of Surgery, Moscow
Russian Federation
Russian Federation
Z. A. Adyrkhaev
A.V. Vishnevsky Institute of Surgery, Moscow
Russian Federation
Russian Federation
Yu. A. Stepanova
A.V. Vishnevsky Institute of Surgery, Moscow
Russian Federation
Russian Federation
V. V. Kazennov
A.V. Vishnevsky Institute of Surgery, Moscow
Russian Federation
Russian Federation
A. E. Zotikov
A.V. Vishnevsky Institute of Surgery, Moscow
Russian Federation
Russian Federation
A. A. Teplov
A.V. Vishnevsky Institute of Surgery, Moscow
Russian Federation
Russian Federation
A. Sh. Revishvili
A.V. Vishnevsky Institute of Surgery, Moscow
Russian Federation
Russian Federation
References
1. Kaprin A.D., Starinskiy V.V., Petrova G.V., eds. Malignancies in Russia in 2013 (morbidity and mortality). Moscow: 2015. 9-15. (In Russian).
2. Shirokorad V.I., Makhson A.N., Yadykova O.A. Status of cancer care in Moscow. Onkourologiya. 2013;4:10–13. (In Russian).
3. Bratslavsky G., Boris R.S. Emerging strategies of nephron sparing surgery in patients with localized and recurrent renal cell carcinoma. Malign Tumours. 2010;1:5–14.
4. Gill I. Laparoscopic radical nephrectomy for cancer. Urol Clin North Am. 2000;27(4):707–719.
5. Matveev B.P., ed. Clinical oncourology. Moscow: ABV-press Publ., 2011. 76–77. (In Russian).
6. Go A.S., Chertow G.M., Fan D., et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(18):1296–1305.
7. Koenig P., Gill I.S., Kamoi K., et al. Kidney cancer and the risk for chronic kidney disease: matched-paired comparison with living donors. J Urol. 2008;179(4):170.
8. McKiernan J., Simmons R., Katz J., Russo P. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology. 2002;59(6):816– 820.
9. Foley R.N., Collins A.J. End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol. 2007;18(10):2644–2648.
10. Foley R.N., Parfrey P.S., Sarnak M.J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112– S119.
11. Rocco M.V., Frankenfield D.L., Hopson S.K., McClellan W.M. Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis. Ann Intern Med. 2006;145(7):512–519.
12. Neil N., Guest S., Wong L., et al. The financial implications for Medicare of greater use of peritoneal dialysis. Clin Ther. 2009;31(4):880–888.
13. Kasiske B.L., Cangro C.B., Hariharan S. The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant. 2001;1 Suppl 2:3–95.
14. Lin S.J., Koford J.K., Baird B.C. The association between length of post-kidney transplant hospitalization and longterm graft and recipient survival. Clin Transplant. 2006;20(2):245–252.
15. Mikich Dzheral'd G.D. Renal cell carcinoma: extracorporeal partial nephrectomy followed by autologous with a localized form of the disease. Onkourologiya. 2007;3:16–20. (In Russian).
16. Clavien P., Sanabria J., Strasberg S. Proposed classification of complication of surgery with examples of utility in cholecystectomy. Surgery. 1992;111(5):518– 526.
17. Bellinger M.F., Koontz Jr. W.W., Smith M.J. Renal cell carcinoma: twenty years of experience. Va Med. 1979;106(4):819– 824.
18. Montie J.E. «Bench surgery» for renal cell carcinoma: a proper niche. Mayo Clin Proc. 1992;67(7):701–702.
19. Petritsch P.H., Gruber H., Colombo T. Indications and results of ex vivo surgery of the kidney. Wien Klin Wochenschr. 1995;107(23):731–735.
20. Stormont T.J., Bilhartz D.L., Zincke H. Pitfalls of «bench surgery» and autotransplantation for renal cell carcinoma. Mayo Clin Proc. 1992;67(7):621–628.
Review
For citations:
Gritskevich A.A., P'yanikin S.S., Adyrkhaev Z.A., Stepanova Yu.A., Kazennov V.V., Zotikov A.E., Teplov A.A., Revishvili A.Sh. Ex vivo kidney resection in pharmacological cold ischemia followed by orthotopic autotransplantation. Transplantologiya. The Russian Journal of Transplantation. 2016;(3):27-36.
Views:
712
Email this article 